GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes

The treatment of nonalcoholic fatty liver disease (NAFLD) remains very challenging. This study investigated the therapeutic effect of galactose oligosaccharide (GOS), an important prebiotic, on NAFLD through in vivo and in vitro experiments and preliminarily explored the mechanism by which GOS impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Shuting, Chen, Jiajia, Bai, Yan, He, Jincan, Cao, Hua, Che, Qishi, Guo, Jiao, Su, Zhengquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268751/
https://www.ncbi.nlm.nih.gov/pubmed/35807929
http://dx.doi.org/10.3390/nu14132749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268751/
https://www.ncbi.nlm.nih.gov/pubmed/35807929
http://dx.doi.org/10.3390/nu14132749

Ejemplares similares